Encouragingly, nearly two-thirds of Americans said they don't feel additional pressure to lose weight now that injectables are available
Though semaglutide had been known to promote weight loss, the results of tirzepatide in reducing body weight reinvigorated the conversation around GLP-1s and weight loss
It's important to note that current research is still in the early stages, with most studies having limited sample sizes and lacking long-term data
There is enormous exuberance about starting GLP-1 drugs, but not nearly enough attention to what happens when people stop, said senior author Ziyad Al-Aly, MD, a WashU Medicine clinical epidemiologist and chief of the Research and Development Service at the VA Saint Louis Health Care System
Additionally, semaglutide slows down the emptying of the stomach, leading to increased feelings of fullness and reduced appetite
I 2 = 0%), or hypoglycemia in patients with T2DM (OR: 1.06, 95% CI: 0.37, 3.07